Cargando…

miRNA-193a-5p repression of p73 controls Cisplatin chemoresistance in primary bone tumors

Osteosarcoma and Ewing Sarcoma are the two most common types of Bone Sarcomas, principally localized at the long bones of the extremities and mainly affecting adolescents and young adults. Cisplatin is one of the current options in the therapeutic arsenal of drugs available to cure these aggressive...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jacques, Camille, Calleja, Lidia Rodriguez, Baud'huin, Marc, Quillard, Thibaut, Heymann, Dominique, Lamoureux, François, Ory, Benjamin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342358/ https://www.ncbi.nlm.nih.gov/pubmed/27486986 http://dx.doi.org/10.18632/oncotarget.10950

Ejemplares similares

The p53 Family Members p63 and p73 Roles in the Metastatic Dissemination: Interactions with microRNAs and TGFβ Pathway
por: Rodriguez Calleja, Lidia, et al.
Publicado: (2022)

Targeting the epigenetic readers in Ewing Sarcoma inhibits the oncogenic transcription factor EWS/Fli1
por: Jacques, Camille, et al.
Publicado: (2016)

Loss of miR-198 and -206 during primary tumor progression enables metastatic dissemination in human osteosarcoma
por: Georges, Steven, et al.
Publicado: (2018)

Implication of the p53-Related miR-34c, -125b, and -203 in the Osteoblastic Differentiation and the Malignant Transformation of Bone Sarcomas
por: Jacques, Camille, et al.
Publicado: (2020)

Clusterin inhibition using OGX-011 synergistically enhances zoledronic acid activity in osteosarcoma
por: Lamoureux, Francois, et al.
Publicado: (2014)

TH1579, MTH1 inhibitor, delays tumour growth and inhibits metastases development in osteosarcoma model
por: Moukengue, Brice, et al.
Publicado: (2020)

Mechanisms of Resistance to Conventional Therapies for Osteosarcoma
por: Marchandet, Louise, et al.
Publicado: (2021)

Ribosomopathies: New Therapeutic Perspectives
por: Orgebin, Emilien, et al.
Publicado: (2020)

Origin and Therapies of Osteosarcoma
por: Moukengue, Brice, et al.
Publicado: (2022)

Molecular Chaperones in Osteosarcoma: Diagnosis and Therapeutic Issues
por: Lallier, Morgane, et al.
Publicado: (2021)

Molecular Alterations Associated with Osteosarcoma Development
por: Ando, Kosei, et al.
Publicado: (2012)

Ewing sarcoma from molecular biology to the clinic
por: Dupuy, Maryne, et al.
Publicado: (2023)

Tracking Targets of Dynamic Super-Enhancers in Vitro to Better Characterize Osteoclastogenesis and to Evaluate the Effect of Diuron on the Maturation of Human Bone Cells
por: Tesfaye, Robel A., et al.
Publicado: (2023)

MiR-193a regulates chemoresistance of human osteosarcoma cells via repression of IRS2
por: Wang, Haiyan, et al.
Publicado: (2019)

The DNA methylation-regulated miR-193a-3p dictates the multi-chemoresistance of bladder cancer via repression of SRSF2/PLAU/HIC2 expression
por: Lv, L, et al.
Publicado: (2014)

Research of the mechanism on miRNA193 in exosomes promotes cisplatin resistance in esophageal cancer cells
por: Shi, Shifeng, et al.
Publicado: (2020)

TNFAIP8 Promotes Cisplatin Chemoresistance in Triple-Negative Breast Cancer by Repressing p53-Mediated miR-205-5p Expression
por: Ma, Hong-Yu, et al.
Publicado: (2020)

Sostdc1: A soluble BMP and Wnt antagonist that is induced by the interaction between myeloma cells and osteoblast lineage cells
por: Faraahi, Z., et al.
Publicado: (2019)

Corrigendum to “Sostdc1: A soluble BMP and Wnt antagonist that is induced by the interaction between myeloma cells and osteoblast lineage cells” [Bone 122 (May 2019) 82–92]
por: Faraahi, Z., et al.
Publicado: (2019)

Interaction of Cutibacterium ( formerly Propionibacterium) acnes with bone cells: a step toward understanding bone and joint infection development
por: Aubin, Guillaume Ghislain, et al.
Publicado: (2017)

Preclinical testing of miRNA-193b-3p mimic in acute myeloid leukemias
por: Issa, Hasan, et al.
Publicado: (2023)

Implication of molecular vascular smooth muscle cell heterogeneity among arterial beds in arterial calcification
por: Espitia, Olivier, et al.
Publicado: (2018)

Retraction Notice to: TNFAIP8 Promotes Cisplatin Chemoresistance in Triple-Negative Breast Cancer by Repressing p53-Mediated miR-205-5p Expression
por: Ma, Hong-Yu, et al.
Publicado: (2023)

P419: HARNESSING MIRNA-193B-3P MIMIC AS A POTENT THERAPEUTIC OPTION IN ACUTE MYELOID LEUKEMIA
por: Issa, Hasan, et al.
Publicado: (2023)

A microRNA-dependent circuit controlling p63/p73 homeostasis: p53 family cross-talk meets therapeutic opportunity
por: Ory, Benjamin, et al.
Publicado: (2011)

The p-adic Simpson correspondence (AM-193)
por: Abbes, Ahmed, et al.
Publicado: (2016)

Preliminary Results of the “Capasquelet” Technique for Managing Femoral Bone Defects—Combining a Masquelet Induced Membrane and Capanna Vascularized Fibula with an Allograft
por: Combal, Alexis, et al.
Publicado: (2021)

Upregulated microRNA‐193a‐3p is responsible for cisplatin resistance in CD44(+) gastric cancer cells
por: Lee, So D., et al.
Publicado: (2018)

Immunostaining of thymidylate synthase and p53 for predicting chemoresistance to S-1/cisplatin in gastric cancer
por: Kamoshida, S, et al.
Publicado: (2007)

MicroRNA-504 modulates osteosarcoma cell chemoresistance to cisplatin by targeting p53
por: Chen, Xin, et al.
Publicado: (2019)

Identification of genomic differences among peripheral arterial beds in atherosclerotic and healthy arteries
por: Steenman, Marja, et al.
Publicado: (2018)

miRNA-378 reverses chemoresistance to cisplatin in lung adenocarcinoma cells by targeting secreted clusterin
por: Chen, Xuesong, et al.
Publicado: (2016)

Epigenetic modification in the expression of p73 p73 - epigenetic target for anticancer therapy
por: Naseer, Faiza, et al.
Publicado: (2019)

HDAC4 Levels Control Sensibility toward Cisplatin in Gastric Cancer via the p53-p73/BIK Pathway
por: Spaety, Marie-Elodie, et al.
Publicado: (2019)

CircLIFR synergizes with MSH2 to attenuate chemoresistance via MutSα/ATM-p73 axis in bladder cancer
por: Zhang, Hui, et al.
Publicado: (2021)

The miR-193a-3p-regulated ING5 gene activates the DNA damage response pathway and inhibits multi-chemoresistance in bladder cancer
por: Li, Yang, et al.
Publicado: (2015)

Role of p73 Dinucleotide Polymorphism in Prostate Cancer and p73 Protein Isoform Balance
por: Carastro, L. Michael, et al.
Publicado: (2014)

MicroRNA-193b-3p represses neuroblastoma cell growth via downregulation of Cyclin D1, MCL-1 and MYCN
por: Roth, Sarah Andrea, et al.
Publicado: (2018)

p53, p63 and p73 in the wonderland of S. cerevisiae
por: Billant, Olivier, et al.
Publicado: (2017)

Cisplatin for cancer therapy and overcoming chemoresistance
por: Ranasinghe, Ranmali, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a35vn3v7hfs46fpl6kh7mt0p8b